Immunology

The field of cardiac lymphatic research has expanded considerably over the past decade. Clinical studies have uncovered lymphatic remodelling in a wide range of cardiovascular diseases, and experimental research has demonstrated that these structural alterations often lead to dysfunction of lymphatic transport. Given the vital physiological role of lymphatics, insufficient lymphatic drainage can affect several aspects of cardiac pathophysiology, including myocardial fluid balance, the immune microenvironment, collagen turnover and lipid handling. In this Review, current knowledge on cardiac lymphatics is summarized, including the structural and molecular specializations underlying their diverse homeostatic functions, and how these features can be altered in cardiovascular diseases. The latest research on the effects of inflammation on lymphatics is presented, together with the mechanisms by which lymphatics modulate immunity. The regulation of cardiac lymphangiogenesis is discussed, including accumulating evidence of immune cell–lymphatic crosstalk in the heart, the role of metabolic and biomechanical stimulation of lymphangiogenesis, and examples of experimental approaches to therapeutic lymphangiogenesis and their current limitations. Finally, areas for future research are highlighted, including the translation of lymphatic imaging and lymphangiogenic therapies to the clinic for patients with cardiovascular disease. In this Review, Brakenhielm summarizes current knowledge on cardiac lymphatics, including structural and molecular features of the lymphatic system, the regulation of cardiac lymphangiogenesis, the lymphatic-mediated modulation of immunity and inflammation, and the alterations in cardiovascular diseases, and discusses potential approaches for therapeutic lymphangiogenesis as well as areas for future research.

The liver, a key metabolic organ, has a central role in maintaining systemic homeostasis but is vulnerable to numerous diseases. Its metabolic functions are mainly carried out by hepatocytes; however, the liver also harbours diverse non-parenchymal cell populations, including immune cells. Among these, Kupffer cells, the resident macrophages of the liver, are critical modulators of liver function and immunity. Emerging research highlights their dynamic roles throughout life, from maintaining tissue homeostasis to shaping the balance between immune tolerance and activation in adulthood. Kupffer cells are located in liver sinusoids, where they act as frontline defenders, clearing pathogens and cellular debris from the circulation. Beyond their established phagocytic and immune regulatory functions, Kupffer cells influence metabolic processes, tissue repair and oncogenesis. Moreover, they shape the response of the liver to metabolic disorders such as metabolic dysfunction-associated steatohepatitis, infections and malignancies, including hepatocellular carcinoma. Here we explore Kupffer cell biology, focusing on the development, heterogeneity and multifaceted roles of these cells in liver health and disease. We further discuss how advances in imaging, transcriptomics and macrophage-targeted therapies can inform future strategies to combat liver-associated health challenges. This Review provides an integrated overview of Kupffer cell biology, from their embryonic origin and spatial organization to their functional specialization within the liver. It emphasizes how Kupffer cells act as immune sentinels while also shaping metabolic regulation, tissue repair, infection and cancer and discusses how emerging technologies are refining our understanding of their context-dependent roles across physiological and pathological settings.

The best time to get an infection might be after a meal, suggest experiments in mice and humans that found that certain immune cells, known as T cells, seem to get a boost from food.

The findings, published today in Nature, could identify ways to improve immune therapies, help physicians to decide when to give vaccinations and eventually show how diet can improve immunity.

Source in comments.

From Immunological Dogma to Immune Plasticity: A Personal Journey Through the Basel Era and Beyond There are moments in science when you realize you are not just learning a field—you are watching it being built in real time. For me, that moment began in Basel Institute for Immunology, during what wa

European Immunisation Week is a good occasion to be reminded about the key role that immunisation plays in preventing diseases and protecting lives.

This year’s theme, “for every generation, vaccines work,” highlights how vaccines have safely protected people, families and communities for generations – and will continue to do so.

HaDEA is managing EU-funded projects working on improving vaccine uptake and literacy and advancing vaccine development.

Discover a selection of these projects and how they contribute to making the EU better prepared for potential future disease outbreaks: https://lnkd.in/ePy6EVMX

#EuropeanImmunisationWeek #EU4Health #HorizonEU

Headline: 📢 Editor-in-Chief's Choice: Why Sex and Gender Matter in Vaccine Efficacy

👏 We are honored to spotlight a high-impact review from our Editor-in-Chief, Prof. Calogero Caruso (Università degli Studi di Palermo), and a distinguished team of experts.
In the realm of personalized medicine, one size does not fit all. Their latest work in Exploration of Immunology breaks down the complex biological and social drivers that cause men and women to react differently to influenza infections and vaccinations.

💡 Key Insights:
▪️ The Immunity Gap: Women generally mount a more robust immune response but are more prone to adverse vaccine reactions.
▪️ The Risk Factor: Men often face a more severe disease trajectory and suboptimal immunogenicity.
▪️ The Drivers: A deep dive into how sex hormones, genetic factors, and gender-related social environments interplay to shape our immune landscape.

This review is a must-read for researchers in immunology, public health, and precision medicine as we strive for more tailored and effective vaccination strategies.

Read the full open-access article here: 🔗 https://lnkd.in/evAzGwS2
#EditorInChief #Immunology #SexDifferences #Influenza #Vaccines #PrecisionMedicine #ExplorationofImmunology #PublicHealth #ScientificResearch

Great news: A new opportunity in immunology education in Portugal! 🎓✨
Find out more information on the Master in Integrative and Systems Immunology (MISI) here ⬇️

How is our understanding of immune memory evolving? Check out our special issue on immune memory, with a beautiful cover from Ester Marina Zárate, PhD from Shane Crotty's lab! The various components and layers of immune memory are depicted as a music emanating from an orchestra, highlighting the importance of coordination and harmonization of the many facets of immune memory—both innate and adaptive—for effective and lasting immune protection. https://lnkd.in/eKp9q3tH

Long considered a cornerstone of protective immunity, immune memory is now being redefined, extending beyond classical adaptive responses to encompass broader, long-lasting changes across the immune system.

In the new Immunity special issue, eight perspectives explore the roles of innate and adaptive memory, from T cells and antibodies to trained immunity and aging. Together, they highlight immune memory as a coordinated, dynamic system, more like an orchestra than a single pathway, shaping effective and lasting protection.

Check out the entire April issue out now, just in time for #IMMUNOLOGY2026 #AAI2026! The American Association of Immunologists

Andrew Oberst Stephen Tait Deepta Bhattacharya Stephen Jameson Sara Hamilton Laura Mackay Thomas Burn Marcus Buggert Claire Gustafson, Ph.D. Joel G. Rurik, PhD Sarah Adamo Luis Barreiro Raúl Aguirre-Gamboa

Immunity is the body's ability to recognize, neutralize, and eliminate harmful foreign substances—such as bacteria, viruses, and toxins—to protect against disease.
This complex defense system is generally categorized into two main branches: Innate and Acquired (Adaptive) immunity.
1. Innate Immunity (Non-Specific)
This is the defense system you are born with. It provides an immediate, "first-line" response to any invader, regardless of what it is.
Physical Barriers: Skin, mucous membranes, and cilia (tiny hairs in the airways).
Chemical Barriers: Stomach acid, enzymes in saliva and tears.
Cellular Defenses: White blood cells like neutrophils and macrophages that engulf and destroy pathogens.
2. Acquired Immunity (Adaptive)
This type of immunity develops throughout your life as you are exposed to diseases or receive vaccines. It is highly specific and "remembers" pathogens for future encounters.
A. Active Immunity
This occurs when your own immune system produces antibodies in response to a pathogen.
Natural Active: Developing immunity after recovering from an infection (e.g., getting chickenpox once).
Artificial Active: Developing immunity via a vaccine (e.g., a flu shot).
B. Passive Immunity
This occurs when you are given antibodies rather than producing them yourself. It provides immediate protection but is temporary.
Natural Passive: Antibodies passed from a mother to her baby through the placenta or breast milk.
Artificial Passive: Receiving an injection of antibodies (e.g., anti-venom for a snake bite or immunoglobulin therapy).
#Biotechnology #SBvvip

For years, CCR5 has been discussed mostly in silos.

HIV people know it as a co-receptor.
Oncology people see it through the tumor microenvironment.
Neurobiology is now showing it may also matter in how injured or malignant tissue stabilizes pathological signaling.

This paper argues that CCR5 is better understood not as a disease-specific target, but as a context-dependent signaling axis that helps organize cell trafficking, intercellular communication, and persistence across biological systems.

In other words:

Different diseases.
Shared signaling logic.

That shift matters, because once you stop viewing disease only through isolated components and start looking at the communication architecture underneath, new therapeutic questions open up.

I’ve posted the paper here as a PDF.
Zenodo link in the comments.

#CCR5
#SystemsBiology
#Immunology
#Oncology
#Neurobiology
#TranslationalMedicine

The OX40/OX40L Axis Promotes Th2 Activity and Impairs Regulatory T Cell Function in Atopic Dermatitis. First author: Kazuhiko Yamamura; corresponding author: Emma Guttman-Yassky


Read the article here: doi.org/10.1111/all.70252


Atopic dermatitis (AD) patients show marked OX40 upregulation in effector and regulatory CD4+ T cells. Interaction with OX40L impairs Treg suppressive function, thereby sustaining Th2 activity and promoting inflammation. Thus, the OX40/OX40L axis drives impaired immune regulation and contributes to enhanced skin inflammation in AD.

#Allergy_journal
Read more articles published in #Allergy on #atopicdermatitis here: https://lnkd.in/dvN_pd2

Recent findings have identified a novel mechanism by which HIV-1 can infect resting T-cells, challenging longstanding assumptions in HIV biology. The research demonstrates that direct cell-to-cell spread of HIV triggers a molecular signaling cascade, temporarily unlocking the nuclear pore complex and allowing viral entry into the nucleus without requiring T-cell activation. This insight provides a new explanation for the persistence of the latent HIV reservoir and highlights potential avenues for targeting these reservoirs. Additionally, the study uncovers new aspects of nuclear transport regulation in immune cells, with broader implications for immunology and therapeutic development.

Tissue-resident regulatory T cells: modulators of local immunity

What is unique about the immune system of people who live to extreme old age? A Review in Nature Reviews Immunology explores how centenarians modulate key hallmarks of immune ageing across innate and adaptive immune compartments.

Read the Review: https://lnkd.in/egQeexbX

In a 2025 #ScienceReview, researchers examined the influence that biological sex exerts on the immune system and immune-related diseases.

Learn more on #DayOfImmunology: https://scim.ag/4s24HdI

B cells have a surprising role in exercise endurance

Study in mice suggests that B cells help to regulate muscle performance.

- B cells are an essential component of humoral immunity, and B cell depletion therapies have clinically succeeded in eliminating cancerous B cells and treating autoimmune diseases.

- Using mouse models, the authors report an immune-independent function of B cells that drives exercise capacity.

- B-cell-deficient mice performed worse on strength and endurance tests than did mice with healthy B-cell counts.

- During exercise, B cell deficiency reduces transforming growth factor (TGF)-β1 production, which alters hepatic glutamate metabolism and decreases blood and muscle glutamate.

- Mechanistically, B cell-derived TGF-β1 transcriptionally upregulates hepatic glutaminase 2 (GLS2) and solute carrier family 7 member 5 (SLC7A5) expression, increasing glutamine catabolism and thus glutamate production in the liver.

- The resulting increase in glutamate fosters skeletal muscle calcium oscillations, calmodulin-dependent protein kinase (CaMK) kinase activity, and mitochondrial biogenesis, thereby improving exercise performance.

-  These findings reveal an immune-independent function of B cells in controlling physical performance and unveil the phenomenon of “immunoexercise,” whereby exercise is modulated by immune cells or immunity.

- Main limitation of this study: there is currently no direct human data on B cells’ maintenance of hepatic Glu metabolism and its exercise improvement; future clinical studies are needed to validate this data in a human setting.

https://lnkd.in/dQ3tS8th
https://lnkd.in/dSN9GGHw

#immunology #Bcells #exercise #science #metabolism

Journal of Human Immunity is the official journal of the International Alliance for Primary Immunodeficiency Societies (IAPIDS) and its member societies.

Editor-in-Chief Jean-Laurent Casanova shares the vision behind JHI and what sets the journal apart in the rapidly evolving field of human immunity.

Excited to share the immunology content guidelines for medical education with the members of the Immunology Teaching Interest Group (ITIG) today at the American Association of Immunologists (AAI) conference. This was a 3-year endeavor with a large task force of dedicated immunology educators that will be published in ImmunoHorizons soon. Thankful to everyone who made this work possible and the support of the AAI Education Committee.
Nicholas Pullen Vijaya Knight (Nagabhushanam) Scott Thompson Michelle Swanson-Mungerson Jennifer Grier Tim Bauler Zhao Yuan Pooja Jain The American Association of Immunologists

Recent research has demonstrated that immune system aging differs significantly between women and men. Analysis of blood samples from nearly 1,000 adults revealed that women experience more pronounced age-related changes, including increased inflammatory immune cells, which may contribute to higher rates of autoimmune diseases, particularly after menopause. In contrast, men exhibit less extensive changes but show an increase in blood cells with pre-leukemia alterations, potentially explaining higher rates of certain blood cancers. These findings highlight the importance of considering biological sex in precision medicine and developing tailored strategies for healthy aging.

Headed to AAI? Don't miss out on all the amazing EDUCATION SESSIONS!
Don't forget to add the Immunology Teaching Interest Group Session on Friday, April 17 in Room 153C from 8-10am to your schedule!
I'll be sharing the findings from the AAI Medical Immunology Task Force in my talk, 'Establishing AAI-Recommended Immunology Content Guidelines for Medical Education in the USA.'
You'll also be able to read about it in ImmunoHorizons - publication coming soon!
Nicholas Pullen

🚨 What if a single immune cell could kill, trap, signal, and even sacrifice itself—all within minutes of infection?🧬🔥
Meet neutrophils — the most abundant and arguably the most underestimated warriors of our immune system.
These cells aren’t just first responders—they are multi-functional combat units executing a coordinated defense strategy:
🔬 Phagocytosis – The Rapid Kill Mechanism
Neutrophils engulf and destroy pathogens within minutes.
📊 Studies show they can phagocytose microbes within 5–10 minutes of encountering them (Kolaczkowska & Kubes, 2013).


🕸️ NETosis – The Ultimate Trap Strategy
They release Neutrophil Extracellular Traps (NETs)—DNA webs laced with antimicrobial proteins.
📊 NETs can immobilize and kill pathogens extracellularly, reducing microbial spread by up to 90% in localized infections (Brinkmann et al., 2004).


💣 Degranulation – Chemical Warfare
Neutrophils release enzymes like elastase and myeloperoxidase.
📊 These enzymes contribute to direct microbial killing and tissue-level pathogen clearance (Borregaard, 2010).


📡 Cytokine Production – Immune System Communication Hub
They secrete cytokines and chemokines to recruit other immune cells.
📊 Neutrophils can produce over 20 different signaling molecules, shaping both innate and adaptive immunity (Tecchio et al., 2014).


⚡ Reactive Oxygen Species (ROS) – Molecular Destruction
Neutrophils generate ROS to destroy pathogens at the biochemical level.
📊 The “respiratory burst” can increase oxygen consumption by up to 10–20 fold during infection (Nathan, 2006).



📊 The Bigger Picture
• Neutrophils make up 50–70% of all circulating white blood cells (Rosales, 2018)
• The human body produces ~100 billion neutrophils daily to maintain immune readiness
• Their lifespan is short—~5–90 hours, yet their impact is immediate and powerful



⚠️ But here’s the twist…
When dysregulated, these same mechanisms contribute to:
➡️ Chronic inflammation
➡️ Autoimmune diseases
➡️ Tissue damage & cancer progression



💡 Final Insight:
Neutrophils are not just defenders—they are precision-engineered immune machines, balancing destruction and communication to protect the body in real time.

👨‍🔬 Curated by Dip Ghosh

#Immunology #Neutrophils #InnateImmunity #MedicalScience #Biotechnology #Research #Healthcare #LifeSciences #ScienceCommunication

👉If you’re enjoying the content and want to support me, consider following:
https://lnkd.in/gVy8G54X

[#PARCC Highlight]: Les cellules NK, nouvelles cibles pour protéger le cœur après un infarctus !
L'insuffisance cardiaque post-infarctus reste un défi médical de taille. L'équipe de Hafid Ait-Oufella au #PARCC vient de publier une étude majeure qui change notre regard sur les mécanismes immunitaires de la réparation cardiaque.

🔬 Qu’est-ce qui est démontré ?
Jusqu'ici, le rôle des cellules Natural Killer (NK) restait flou dans les maladies cardiaques. Cette étude démontre que :
  📍  Après un infarctus, les cellules NK sont recrutées vers le cœur (via l'axe CCR2) et libèrent du granzyme B, provoquant la mort des cardiomyocytes.
   📍 Elles stimulent la production de cellules inflammatoires myéloïdes dans la moelle osseuse (via le GM-CSF).
   📍 La déplétion de ces cellules réduit l'inflammation et améliore significativement la fonction cardiaque.

🌟 Pourquoi c’est important ?
📌 Les cellules NK deviennent une cible innovante pour de futurs traitements immunomodulateurs.
📌 L'identification d'une signature transcriptomique chez l'humain confirme le potentiel thérapeutique de cette découverte.
📌 Cette étude ouvre la voie à des stratégies d'immuno-thérapie pour limiter les séquelles et prévenir l'insuffisance cardiaque chronique.

🤝 Une synergie d'expertise au PARCC, ce travail n'aurait pu voir le jour sans une collaboration étroite entre plusieurs équipes du PARCC : les équipes de Jean-Sébastien Silvestre & Jean-Sébastien Hulot, Clément Cochain et Alexandre Loupy

👏 Félicitations à tous et également à tous les collaborateurs pour ce magnifique succès collectif ! 👏

Raphaël Cohen-Belmatoug Vincent Duval Rida Al-Rifai Icia Santos Zas Charlène Jouve Sara Thietart Théo Guyon Marie Piollet Soraya Taleb Eric Vivier Giuseppe Rizzo Olivier Hermine Sikander Hayat
Faculté de Santé - Université Paris Cité Inserm Paris / Île-de-France Tatiana Monseur Mohamed ABOU ALI POLYGON Therapeutics

🔗 Pour en savoir plus: https://lnkd.in/eqUEnvtU

#Cardiology #Research #NatureCommunications #PARCC #Inserm #UPCité #HeartFailure #Immunology #ScienceInnovation